About THISX
T. Rowe Price Health Sciences Fund I Class is an institutional mutual fund that focuses on achieving long-term capital appreciation by investing primarily in companies operating within the health sciences sector. This includes firms engaged in the research, development, production, or distribution of healthcare products and services, encompassing the pharmaceutical, healthcare services, and life sciences industries. The fund adopts a flexible approach, investing across companies of various sizes, though it tends to emphasize large- and mid-capitalization firms. Utilizing fundamental, bottom-up analysis, the fund seeks to identify high-quality businesses with compelling growth opportunities, but may also employ a value-oriented strategy when valuations appear elevated. While its portfolio is primarily composed of U.S. equities, the fund may also hold international and private companies to meet its objectives. With over 140 holdings and a notable presence in the healthcare market, the T. Rowe Price Health Sciences Fund I Class serves institutional investors seeking targeted exposure to innovations and growth trends within the broader healthcare and life sciences landscape.
Fund Family T. Rowe Price
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange Nasdaq
Ticker Symbol THISX
Share Class T. Rowe Price Health Sciences Fund-i Class
Index S&P 500 TR
THISX had a total return of 26.37% in the past year, including dividends. Since the fund's
inception, the average annual return has been 13.88%.
